How to get the most out of Wegovy — practical guidance from the evidence

What the STEP 1 data actually shows about lifestyle, and why it matters to you

The STEP 1 trial is the cornerstone evidence behind Wegovy's UK licence. Over 68 weeks, adults taking semaglutide 2.4mg lost around 15% of their body weight on average, and you can read about how much weight people have actually lost on Wegovy to get a sense of the full range of outcomes. That is a meaningful result, but the trial design is worth understanding: every participant received structured lifestyle support alongside the injection. Diet counselling, activity targets and behavioural coaching were all in play.

What the data does not show is what happens when someone takes Wegovy with no dietary change at all. The honest reading is that the medicine creates a powerful biological advantage (a real reduction in hunger that makes eating less considerably easier) and the lifestyle element converts that advantage into lasting results. Think of it as the medicine clearing the path; you still walk it.

NHS guidance on semaglutide echoes this framing, recommending Wegovy as part of a weight-management plan that includes a reduced-calorie diet and more physical activity. Starting with that understanding tends to produce better outcomes than treating the pen as a standalone fix. Our guide to maximising weight loss on Wegovy goes deeper on the numbers.

Nutrition on Wegovy: what tends to work when appetite is suppressed

One of the most common things people notice in the first weeks is that portion sizes feel naturally smaller. That is the GLP-1 mechanism doing its job. The practical risk is eating so little that protein intake drops too low, which accelerates muscle loss alongside fat loss.

Prioritising protein at each meal is the single most widely supported dietary adjustment for people on GLP-1 treatment. Lean meat, fish, eggs, dairy and legumes are straightforward sources. Aiming to hit a reasonable protein target before filling the rest of the plate tends to work better than calorie-counting alone when appetite is unreliable.

Hydration matters too. Nausea and reduced appetite can mean people drink less without realising, and mild dehydration makes nausea worse, a cycle worth breaking early. Small, frequent meals rather than large ones can ease the gastric-emptying effect in the early months of treatment.

Fibre is worth a mention here as well: vegetables, wholegrains, legumes and fruit support gut motility, which matters because constipation is a common side effect in the early titration phase. A question our prescribers hear regularly is whether supplements are needed. For most people, a food-first approach works; your prescriber is the right person to assess your individual situation. You can also explore when Wegovy tends to work best for more on the clinical picture.

Movement, muscle and the long-term picture

Physical activity on Wegovy does two things: it burns calories and, critically, it sends a signal to the body to preserve lean muscle. When calorie intake falls (which it will, meaningfully, on semaglutide, the active ingredient behind Wegovy and how it works) the body has a tendency to use muscle as fuel alongside fat unless resistance work gives it a reason not to.

This does not mean aggressive gym sessions from week one. Resistance training two to three times a week, even bodyweight work at home, is enough to make a difference. Walking counts too: NHS Better Health guidance supports building daily movement gradually, and the research behind Wegovy was designed with exactly that kind of realistic activity in mind.

The timeline matters. Many people notice the most rapid weight loss in the first three to six months as doses increase. After that, the rate naturally slows, that is biology, not failure. Understanding the typical timeline of weight loss on Wegovy helps set realistic expectations and avoid discouragement during the plateau phase.

Staying on track: side effects, clinical review and what to expect

Nausea, loose stools and constipation are the most commonly reported side effects, particularly after starting or after each dose increase. They are usually mild and settle within a week or two for most people. Eating smaller portions, avoiding very fatty or spicy food early on, and staying hydrated are all practical measures that help.

Serious side effects are uncommon, but it is worth knowing the signals that need prompt medical attention: severe stomach pain that persists or radiates to the back could indicate pancreatitis and should be assessed the same day. Report any unexpected symptoms to your prescriber and, if appropriate, via the MHRA Yellow Card scheme.

Clinical review is not optional extra. Every repeat order through a regulated service should involve a prescriber checking that treatment is still working and still appropriate. At nume, your clinical team reviews each repeat before anything is dispatched, your consultation lands with a real prescriber, not a form processor. When your treatment is approved and dispatched, it arrives via DPD in plain, unbranded packaging the next working day.

If you are weighing up which semaglutide treatment fits your situation, the evidence on semaglutide effectiveness is a useful starting point. And if you are ready to see whether Wegovy is clinically suitable for you, start your free consultation with our prescribers today.